Mark L. Weber

1.6k total citations
31 papers, 1.3k citations indexed

About

Mark L. Weber is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Ophthalmology. According to data from OpenAlex, Mark L. Weber has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 4 papers in Ophthalmology. Recurrent topics in Mark L. Weber's work include Neuroscience and Neuropharmacology Research (16 papers), Ion channel regulation and function (6 papers) and Receptor Mechanisms and Signaling (4 papers). Mark L. Weber is often cited by papers focused on Neuroscience and Neuropharmacology Research (16 papers), Ion channel regulation and function (6 papers) and Receptor Mechanisms and Signaling (4 papers). Mark L. Weber collaborates with scholars based in United States, Germany and United Kingdom. Mark L. Weber's co-authors include Charles P. Taylor, Arup Das, Richard M. LoPachin, Ellen J. Lehning, Michael A. Mancini, Robert N. Frank, Sean D. Donevan, András Kovács, HS Jacob and Mark G. Vartanian and has published in prestigious journals such as Journal of Neuroscience, PLoS ONE and Brain Research.

In The Last Decade

Mark L. Weber

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark L. Weber United States 20 560 517 240 115 105 31 1.3k
Rachel Butler United Kingdom 19 1.0k 1.8× 602 1.2× 166 0.7× 75 0.7× 59 0.6× 33 2.0k
Björn Kull Sweden 22 1.6k 2.9× 946 1.8× 253 1.1× 249 2.2× 161 1.5× 32 3.3k
Margaret M. Zaleska United States 19 570 1.0× 344 0.7× 329 1.4× 233 2.0× 45 0.4× 39 1.4k
Timothy Angelotti United States 14 509 0.9× 449 0.9× 235 1.0× 47 0.4× 144 1.4× 34 1.1k
Susanna M.O. Hourani United Kingdom 26 678 1.2× 483 0.9× 373 1.6× 85 0.7× 136 1.3× 56 2.0k
Ruth A. Steingart Israel 17 514 0.9× 435 0.8× 250 1.0× 66 0.6× 53 0.5× 22 1.2k
Takeo Fukuda Japan 19 289 0.5× 466 0.9× 222 0.9× 33 0.3× 90 0.9× 80 1.2k
R. S. Bourke United States 17 592 1.1× 569 1.1× 149 0.6× 168 1.5× 58 0.6× 27 1.2k
Allen Barnett United States 19 724 1.3× 861 1.7× 165 0.7× 22 0.2× 113 1.1× 38 1.4k
Nagaraju Akula United States 10 415 0.7× 224 0.4× 140 0.6× 188 1.6× 48 0.5× 14 1.0k

Countries citing papers authored by Mark L. Weber

Since Specialization
Citations

This map shows the geographic impact of Mark L. Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Weber more than expected).

Fields of papers citing papers by Mark L. Weber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Weber. The network helps show where Mark L. Weber may publish in the future.

Co-authorship network of co-authors of Mark L. Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Weber. A scholar is included among the top collaborators of Mark L. Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Weber. Mark L. Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reinhart, Veronica, Thomas A. Lanz, Mark L. Weber, et al.. (2021). Schizophrenia-associated SLC39A8 polymorphism is a loss-of-function allele altering glutamate receptor and innate immune signaling. Translational Psychiatry. 11(1). 136–136. 19 indexed citations
2.
Malik, Ruchi, Thomas A. Lanz, Mark L. Weber, et al.. (2020). GluN2D-mediated excitatory drive onto medial prefrontal cortical PV+ fast-spiking inhibitory interneurons. PLoS ONE. 15(6). e0233895–e0233895. 24 indexed citations
3.
Dutra, Jason K., Mark L. Weber, Jincheng Pang, et al.. (2019). Pharmacological evaluation of clinically relevant concentrations of (2R,6R)-hydroxynorketamine. Neuropharmacology. 153. 73–81. 22 indexed citations
4.
Weber, Mark L., Christopher L. Shaffer, Gunnar Flik, et al.. (2013). Therapeutic doses of antidepressants are projected not to inhibit human α4β2 nicotinic acetylcholine receptors. Neuropharmacology. 72. 88–95. 15 indexed citations
5.
Shaffer, Christopher L., Raymond S Hurst, Renato J. Scialis, et al.. (2013). Positive Allosteric Modulation of AMPA Receptors from Efficacy to Toxicity: The Interspecies Exposure-Response Continuum of the Novel Potentiator PF-4778574. Journal of Pharmacology and Experimental Therapeutics. 347(1). 212–224. 44 indexed citations
6.
Ariza, Liana, et al.. (2012). Investigation of a scabies outbreak in a kindergarten in Constance, Germany. European Journal of Clinical Microbiology & Infectious Diseases. 32(3). 373–380. 28 indexed citations
7.
Li, Zheng, Charles P. Taylor, Mark L. Weber, et al.. (2011). Pregabalin is a potent and selective ligand for α2δ-1 and α2δ-2 calcium channel subunits. European Journal of Pharmacology. 667(1-3). 80–90. 119 indexed citations
8.
Belliotti, Thomas R., Thomas Capiris, Jack J. Kinsora, et al.. (2005). Structure−Activity Relationships of Pregabalin and Analogues That Target the α2-δ Protein. Journal of Medicinal Chemistry. 48(7). 2294–2307. 173 indexed citations
9.
Weber, Mark L., et al.. (2005). Mediation of Highly Concentrative Uptake of Pregabalin by L-Type Amino Acid Transport in Chinese Hamster Ovary and Caco-2 Cells. Journal of Pharmacology and Experimental Therapeutics. 313(3). 1406–1415. 71 indexed citations
10.
LoPachin, Richard M., et al.. (2001). Effects of ion channel blockade on the distribution of Na, K, Ca and other elements in oxygen-glucose deprived CA1 hippocampal neurons. Neuroscience. 103(4). 971–983. 53 indexed citations
11.
Hu, Lain‐Yen, Todd R. Ryder, Michael Rafferty, et al.. (1999). N,N-Dialkyl-dipeptidylamines as novel N-type calcium channel blockers. Bioorganic & Medicinal Chemistry Letters. 9(6). 907–912. 14 indexed citations
12.
Ryder, Todd R., Lain‐Yen Hu, Michael Rafferty, et al.. (1999). Structure-activity relationship at the proximal phenyl group in a series of non-peptidyl N-type calcium channel antagonists. Bioorganic & Medicinal Chemistry Letters. 9(16). 2453–2458. 7 indexed citations
13.
Weber, Mark L. & Charles P. Taylor. (1994). Damage from oxygen and glucose deprivation in hippocampal slices is prevented by tetrodotoxin, lidocaine and phenytoin without blockade of action potentials. Brain Research. 664(1-2). 167–177. 101 indexed citations
14.
Taylor, Charles P. & Mark L. Weber. (1993). Effect of temperature on synaptic function after reduced oxygen and glucose in hippocampal slices. Neuroscience. 52(3). 555–562. 49 indexed citations
15.
Marcoux, F, Mark L. Weber, Albert W. Probert, & Mark A. Dominick. (1992). Hypoxic Neurodegeneration in Culture: Calcium Influx, Electron Microscopy, and Neuroprotection with Excitatory Amino Acid Antagonists. Annals of the New York Academy of Sciences. 648(1). 303–305. 5 indexed citations
16.
Madden, K P, Wayne M. Clark, F Marcoux, et al.. (1990). Treatment with conotoxin, an ‘N-type’ calcium channel blocker, in neuronal hypoxic-ischemic injury. Brain Research. 537(1-2). 256–262. 35 indexed citations
17.
Weber, Mark L., Michael A. Mancini, & Robert N. Frank. (1989). Retinovitreal neovascularization in the Royal College of Surgeons rat. Current Eye Research. 8(1). 61–74. 27 indexed citations
18.
Das, Arup, et al.. (1989). A Model of Subretinal Neovascularization in the Pigmented Rat. Current Eye Research. 8(3). 239–247. 56 indexed citations
19.
Das, Arup, Robert N. Frank, Mark L. Weber, et al.. (1988). ATP causes retinal pericytes to contract in vitro. Experimental Eye Research. 46(3). 349–362. 62 indexed citations
20.
Larbrisseau, Albert, et al.. (1980). [Trichopoliodystrophy or Menkes disease].. PubMed Central. 123(6). 490–7. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rachel Butler Breakdown of academic impact, for papers by Björn Kull Breakdown of academic impact, for papers by Margaret M. Zaleska Breakdown of academic impact, for papers by Timothy Angelotti Breakdown of academic impact, for papers by Susanna M.O. Hourani Breakdown of academic impact, for papers by Ruth A. Steingart Breakdown of academic impact, for papers by Takeo Fukuda Breakdown of academic impact, for papers by R. S. Bourke Breakdown of academic impact, for papers by Allen Barnett Breakdown of academic impact, for papers by Nagaraju Akula
Rankless by CCL
2026